Mannitol Completed Phase 2 Trials for Cystic Fibrosis (CF) Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT01883531Crossover Trial Determining the Efficacy of Dry Powder Mannitol to Improve Lung Function in Subjects Aged 6-17 Years
NCT00251056Mannitol Dose Response Study in Cystic Fibrosis
NCT00117208Comparison of Inhaled Mannitol and rhDNase in Children With Cystic Fibrosis